COMMUNIQUÉS West-GlobeNewswire

-
Ohr Pharmaceutical Urges Stockholders to Vote “FOR” Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019
03/07/2019 -
DRAFT RESOLUTIONS of Extraordinary General Meeting of Shareholders of joint stock company “Grindeks” to be held on 17 July 2019
03/07/2019 -
INmune Bio Co-Founder and CEO Presents at Maxim Group’s Conference on Alzheimer’s Disease
03/07/2019 -
Philips ships two-millionth AED, helping to save lives across the globe
03/07/2019 -
OrthoPediatrics Corp. to Sponsor 26th Annual International Meeting on Advanced Spine Techniques (IMAST)
03/07/2019 -
Auris Medical Completes Enrollment of Phase 1b Proof-Of-Concept Trial of AM-201 in Antipsychotic-Induced Weight Gain
03/07/2019 -
Zosano Pharma Announces Keynote Speech at the Pharmaceutics & Advanced Drug Delivery Systems Conference
03/07/2019 -
PDS Biotechnology Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2019 -
Ziopharm Oncology Names NCI’s Dr. Drew Deniger to Direct TCR-T Cell Therapy Program
03/07/2019 -
REPEAT - AgraFlora Organics Awarded Health Canada Hemp Production License; To Immediately Stream High CBD Cultivars to Edibles and Beverage Manufacturing Asset Portfolio
03/07/2019 -
The Yogen Früz Brain Project encourages Canadians to get a ”head start” on brain health
03/07/2019 -
Kohlberg & Company acquiert Nelipak® Healthcare Packaging
03/07/2019 -
T2 Biosystems Reports Granting of Inducement Awards
03/07/2019 -
VitalHub Featured in 2019 Branham300 List of Top ICT Companies
03/07/2019 -
Information regarding the results of mandatory redemption of shares
03/07/2019 -
La coentreprise Emerald Health Therapeutics lance au Canada un supplément de santé sans cannabis soutenant le système endocannabinoïde
03/07/2019 -
BioCryst Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
03/07/2019 -
Precision Biomonitoring and AgriSeq Solutions Announce Strategic Partnership in Genomics
03/07/2019 -
Algernon Pharmaceuticals’ NP-120 Reduced Fibrosis in an Idiopathic Pulmonary Fibrosis Study by 56% Outperforming USFDA Approved Treatments Nintedanib and Pirfenidone
03/07/2019
Pages